Sign up to save your podcasts
Or
Share Episode 129: estimating mortality in acute HF, a new migraine drug, and 15 year f/u of the largest RCT of prostate CA treatment
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 129: estimating mortality in acute HF, a new migraine drug, and 15 year f/u of the largest RCT of prostate CA treatment
Kate, Gary and Henry discuss 3 new studies: a clinical decision support tool to assess mortality risk in patients presenting with acute heart failure, a new intranasal medication for treating acute migraine attacks, and the pros and cons of different approaches to treatment of low grade prostate cancer.
View all episodes
By Mark Ebell
4.7
9292 ratings
Kate, Gary and Henry discuss 3 new studies: a clinical decision support tool to assess mortality risk in patients presenting with acute heart failure, a new intranasal medication for treating acute migraine attacks, and the pros and cons of different approaches to treatment of low grade prostate cancer.
More shows like Primary Care Update
View all
JAMA Editors' Summary
137 Listeners
AFP: American Family Physician Podcast
703 Listeners
JAMA Clinical Reviews
498 Listeners
Mayo Clinic Talks
289 Listeners
GeriPal - A Geriatrics and Palliative Medicine Podcast
287 Listeners
Frankly Speaking About Family Medicine
263 Listeners
The Curbsiders Internal Medicine Podcast
3,339 Listeners
Core IM | Internal Medicine Podcast
1,151 Listeners
Annals On Call Podcast
191 Listeners
JAMA Medical News
88 Listeners
The Clinical Problem Solvers
513 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
367 Listeners
Run the List
249 Listeners
The Curious Clinicians
372 Listeners
The Cribsiders
315 Listeners